Teva Pharmaceutical Industries | TEVA - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Aspen Pharmacare ZAR 10.14B 830M 2024-06
Cipla INR 44.1B 5B 2026-06
Dr.Reddys Laboratories INR 41.78B 4.02B 2026-06
Guangzhou Baiy CNY 4.73B 3.03B 2026-03
Jiangsu Hengrui CNY 7.27B 918.27M 2025-12
Kalbe Farma IDR 3.66T 214.43B 2026-03
Richter Gedeon HUF 143.37B 25.78B 2025-09
Sh Fosun Pharma CNY 6.69B 1.9B 2025-12
Sun Pharmaceuticals INR 125.24B 17.58B 2025-12
Teva Pharmaceutical Industries USD 2.11B 547M 2026-03